Human Longevity last raised $32.0M in its Early Stage VC (Mar 2023).
- ·The complete investor list: 36 names
- ·Watch Human Longevity: the Monday email on marks, rounds and moves
Human Longevity funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2023 | Early Stage VC | $32.0M | ▮ | ▮ |
| Sep 2021 | Early Stage VC | $6.9M | ▮ | ▮ |
| Jun 2019 | Early Stage VC | $20.1M | ▮ | ▮ |
Membership and data by Private Market View
Human Longevity valuation
Human Longevity's last known valuation is $250 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Human Longevity raised?
Human Longevity has raised $1.1 billion in total; 3 of its rounds are on record, from 2019 on. The largest on record was a $6.9 million early-stage round in Sep 2021; the most recent was a $32 million early-stage round in Mar 2023.
Human Longevity has filed 4 Form Ds with the SEC since 2019, most recently in Aug 2024 ($32 million sold to 18 investors).
How Human Longevity's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Human Longevity, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Human Longevity
- What is Human Longevity worth?
- Human Longevity's last known valuation is $250.0M.
- How much has Human Longevity raised?
- Human Longevity has raised $1.1B in total funding across 3 recorded rounds.
- When did Human Longevity last raise?
- Human Longevity last raised in Mar 2023 (Early Stage VC), raising $32.0M.